Duloxetine
Product manufactured by Actavis Pharma, Inc.
Indications and Purposes
| 1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: Major Depressive Disorder [See Clinical Studies (14.1) ] Generalized Anxiety Disorder [See Clinical Studies (14.2) ] Diabetic Peripheral Neuropathy [See Clinical Studies (14.3) ] Fibromyalgia [See Clinical Studies (14.4) ] Chronic Musculoskeletal Pain [See Clinical Studies (14.5) ] Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: Major Depressive Disorder (Mdd) ( 1 ) Generalized Anxiety Disorder (Gad) ( 1 ) Diabetic Peripheral Neuropathic Pain (Dpnp) ( 1 ) Fibromyalgia (Fm) ( 1 ) Chronic Musculoskeletal Pain ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Duloxetine Hydrochloride |
|
ZINC1536779 |